Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in Japan.
Yoshimura A, Kato T, Nakai Y, Tsujihata M, Toyoda S, Sato M, Matsuzaki K, Nakata W, Takao T, Inoguchi S, Okuda Y, Yamamichi G, Ishizuya Y, Yamamoto Y, Hatano K, Kawashima A, Takada S, Inoue H, Nishimura K, Miyake O, Fujita K, Nakayama M, Nishimura K, Nonomura N.
Yoshimura A, et al. Among authors: matsuzaki k.
Int J Clin Oncol. 2024 Sep 2. doi: 10.1007/s10147-024-02612-1. Online ahead of print.
Int J Clin Oncol. 2024.
PMID: 39222148